Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro Following Single Dose Administration in Elderly and Younger Adults With Type 1 Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 20 Oct 2017 Planned End Date changed from 1 Apr 2018 to 1 Nov 2017.
- 20 Oct 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Nov 2017.
- 20 Oct 2017 Status changed from recruiting to active, no longer recruiting.